Table 2 Clinical characteristics of the diseased groups
From: Serum Krebs von den Lungen (KL-6) level as a marker of exacerbation of interstitial lung diseases
Group I (stable), N = 26 | Group II (exacerbation), N = 47 | p value | |
|---|---|---|---|
Fever | |||
Yes | 1 (3.8%) | 17 (36.2%) | 0.002 |
No | 25 (96.2%) | 30 (63.8%) | |
Signs of RHF | |||
Lower limb edema | |||
Yes | 2 (7.7%) | 25 (53.2%) | < 0.001 |
No | 24 (92.3%) | 22 (46.8%) | |
Congested veins | |||
Yes | 0 (0%) | 9 (19.1%) | 0.022 |
No | 26 (100%) | 38 (80.9%) | |
mMRC | |||
II | 9 (34.6%) | 4 (8.5%) | 0.004 |
III | 16 (61.5%) | 30 (63.8%) | |
IV | 1 (3.8%) | 13 (27.7%) | |